UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cooperative Catalysis at Metal–Sulfur Bonds

Accounts of chemical research, 2017-05, Vol.50 (5), p.1258-1269

2017

Volltextzugriff (PDF)

Top predators rely on carbon derived from giant kelp Macrocystis pyrifera

Marine ecology. Progress series (Halstenbek), 2015-10, Vol.537, p.1-8

2015

Volltextzugriff (PDF)

PB1301 Low-Titer Inhibitor and Decreased FVIII Activity to 1.1% with Increased Bleeding in a 4 Year Old Patient with Congenital Mild Hemophilia A

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101098, Article 101098

2023

Volltextzugriff (PDF)

Catalytic 1,4-Selective Hydrosilylation of Pyridines and Benzannulated Congeners

Angewandte Chemie International Edition, 2013-09, Vol.52 (38), p.10076-10079

International ed. in English, 2013

Volltextzugriff (PDF)

Mechanism of the cooperative Si-H bond activation at Ru-S bonds

Chemical science (Cambridge), 2015-07, Vol.6 (7), p.4324-4334

2015

Volltextzugriff (PDF)

SU‐GG‐T‐136: Real Time Delivery Verification Using Exit Detector Data

Medical Physics, 2008-06, Vol.35 (6), p.2757-2757

2008

Volltextzugriff (PDF)

OC 69.2 Costimulatory Domains of Second- and Third-Generation CAR-Tregs affect the Type of FVIII-Specific Treg Responses and Might be able to Stabilize the Treg Phenotype

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100467, Article 100467

2023

Volltextzugriff (PDF)

PB0670 Nationwide Survey on the Care Reality of People with Mild Hemophilia A and B in Germany - The Burden of Mild Hemophilia

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101167, Article 101167

2023

Volltextzugriff (PDF)

Catalytic dehydrogenative Si-N coupling of pyrroles, indoles, carbazoles as well as anilines with hydrosilanes without added base

Chemical communications (Cambridge, England), 2013-01, Vol.49 (15), p.1506-1508

2013

Volltextzugriff (PDF)

Need for therapeutic drug monitoring in HIV-1 infected children receiving efavirenz doses according to international guidelines

European journal of medical research, 2006-09, Vol.11 (9), p.377-380

2006

Volltextzugriff (PDF)

Mode of delivery in hemophilia: vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds

Haematologica (Roma), 2019-10, Vol.104 (10), p.2100-2106

2019

Volltextzugriff (PDF)

Base-Free Dehydrogenative Coupling of Enolizable Carbonyl Compounds with Silanes

Organic letters, 2012-06, Vol.14 (11), p.2842-2845

2012

Volltextzugriff (PDF)

Elimination of factor VIII‐specific B cells by immunotoxins composed of a single factor VIII domain fused to Pseudomonas exotoxin A

Journal of thrombosis and haemostasis, 2018-11, Vol.16 (11), p.2223-2232

2018

Volltextzugriff (PDF)

OC 43.1 A Survey on Clinical Praxis in Initiating Emicizumab Prophylaxis in Previously Untreated Patients in the PedNet Centers

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100440, Article 100440

2023

Volltextzugriff (PDF)

Regulatory T cells and their potential for tolerance induction in haemophilia A patients

Hamostaseologie, 2016-11, Vol.36 (Suppl. 2), p.S5

2016

Volltextzugriff (PDF)

PB0649 Results from the RESIST Study for Tolerance Induction in Patients with Poor Prognosis for ITI Success

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101189, Article 101189

2023

Volltextzugriff (PDF)

New predictive approaches for ITI treatment

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-09, Vol.20 (s6), p.27-43

2014

Volltextzugriff (PDF)

Lupus anticoagulants associated inhibitor against factor IX in a young patient with haemophilia B

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-09, Vol.22 (5), p.e437-e439

2016

Volltextzugriff (PDF)

Pregnancy complications in HIV‐positive women: 11‐year data from the Frankfurt HIV Cohort

HIV medicine, 2014-10, Vol.15 (9), p.525-536

2014

Volltextzugriff (PDF)

Next generation FIX muteins with FVIII‐independent activity for alternative treatment of hemophilia A

Journal of thrombosis and haemostasis, 2014-11, Vol.12 (11), p.1861-1873

2014

Volltextzugriff (PDF)

Percentiles of Lymphocyte Subsets in Preterm Infants According to Gestational Age Compared to Children and Adolescents

Scandinavian journal of immunology, 2016-11, Vol.84 (5), p.291-298

2016

Volltextzugriff (PDF)

CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand

HIV medicine, 2019-08, Vol.20 (7), p.456-472

2019

Volltextzugriff (PDF)

LB 01.1 Efanesoctocog Alfa Prophylaxis for Previously Treated Patients <12 Years of Age with Severe Hemophilia A

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100288, Article 100288

2023

Volltextzugriff (PDF)

Oral gene therapy for hemophilia B using chitosan‐formulated FIX mutants

Journal of thrombosis and haemostasis, 2014-06, Vol.12 (6), p.932-942

2014

Volltextzugriff (PDF)

1 – 25 von 535

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(294)
Mit Volltextzugriff
(472)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cooperative Catalysis at Metal–Sulfur Bonds

Top predators rely on carbon derived from giant kelp Macrocystis pyrifera

PB1301 Low-Titer Inhibitor and Decreased FVIII Activity to 1.1% with Increased Bleeding in a 4 Year Old Patient with Congenital Mild Hemophilia A

Catalytic 1,4-Selective Hydrosilylation of Pyridines and Benzannulated Congeners

Mechanism of the cooperative Si-H bond activation at Ru-S bonds

SU‐GG‐T‐136: Real Time Delivery Verification Using Exit Detector Data

OC 69.2 Costimulatory Domains of Second- and Third-Generation CAR-Tregs affect the Type of FVIII-Specific Treg Responses and Might be able to Stabilize the Treg Phenotype

PB0670 Nationwide Survey on the Care Reality of People with Mild Hemophilia A and B in Germany - The Burden of Mild Hemophilia

Catalytic dehydrogenative Si-N coupling of pyrroles, indoles, carbazoles as well as anilines with hydrosilanes without added base

Need for therapeutic drug monitoring in HIV-1 infected children receiving efavirenz doses according to international guidelines

Mode of delivery in hemophilia: vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds

Base-Free Dehydrogenative Coupling of Enolizable Carbonyl Compounds with Silanes

Elimination of factor VIII‐specific B cells by immunotoxins composed of a single factor VIII domain fused to Pseudomonas exotoxin A

99.3% of Inhibitors in Severe Hemophilia a Develop before Exposure Day 75. Time to Change Definition of Previously Treated Patients; Data from 1038 Patients with Severe Hemophilia a of the Pednet Registry

OC 43.1 A Survey on Clinical Praxis in Initiating Emicizumab Prophylaxis in Previously Untreated Patients in the PedNet Centers

Regulatory T cells and their potential for tolerance induction in haemophilia A patients

PB0649 Results from the RESIST Study for Tolerance Induction in Patients with Poor Prognosis for ITI Success

New predictive approaches for ITI treatment

Lupus anticoagulants associated inhibitor against factor IX in a young patient with haemophilia B

Pregnancy complications in HIV‐positive women: 11‐year data from the Frankfurt HIV Cohort

Next generation FIX muteins with FVIII‐independent activity for alternative treatment of hemophilia A

Percentiles of Lymphocyte Subsets in Preterm Infants According to Gestational Age Compared to Children and Adolescents

CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand

LB 01.1 Efanesoctocog Alfa Prophylaxis for Previously Treated Patients <12 Years of Age with Severe Hemophilia A

Oral gene therapy for hemophilia B using chitosan‐formulated FIX mutants

Suchergebnisse filtern